Articles
NANS Publishes New Curriculum for Deep Brain Stimulation (DBS) Training
The North American Neuromodulation Society (NANS) has published a new consensus curriculum for deep brain stimulation (DBS) implantation training.
NANS Urges UnitedHealthcare to Revisit Stroke Therapy Coverage
The North American Neuromodulation Society (NANS) is calling on UnitedHealthcare (UHC) to reconsider its policy denying coverage for implantable vagus nerve stimulation (iVNS) paired with rehabilitation for stroke recovery.
NANS Joins Coalition Urging Action on No Surprises Act Implementation
The North American Neuromodulation Society (NANS) has joined more than 100 medical organizations in a joint letter to federal agencies raising concerns about how the No Surprises Act (NSA) is being implemented.
NANS, Medical Societies Urge Elevance Health to Reconsider PNS Coverage
The North American Neuromodulation Society (NANS), alongside several leading medical societies, recently submitted a joint…
NANS Joins Multisociety Advocacy on Trigger Point Injection Policy
NANS joined a coalition of leading medical societies in submitting formal comment letters to First Coast Service Options and Novitas regarding the proposed LCD for trigger point injections (TPIs).
NANS Applauds Aetna for Revising Policy on Peripheral Electrical Nerve Stimulation for Pain Policy
The North American Neuromodulation Society (NANS) recognizes Aetna for updating its clinical policy on peripheral electrical nerve stimulation (PNS) for pain, expanding access to non-pharmacological treatment options for patients with chronic pain.
NANS Opens Public Comment on Draft PNS Guideline
The North American Neuromodulation Society (NANS) has opened the public comment period for its draft Clinical Guideline on Implantable Peripheral Nerve Stimulation (PNS) for Chronic Pain—one of the first formal guideline initiatives undertaken by the Society.
NANS Joins Multi-Society Effort on PNS Coverage
The North American Neuromodulation Society (NANS) joined several leading medical specialty societies in submitting joint letters to Cigna Healthcare and UnitedHealthcare regarding policies that classify peripheral nerve stimulation (PNS) as investigational for the treatment of chronic pain.
NANS Joins Multi-Society Comments on Proposed BVN Coverage Policy
The North American Neuromodulation Society (NANS), alongside leading national pain and spine organizations, has submitted a joint comment letter to National Government Services (NGS) regarding its proposed Local Coverage Determination (LCD) for thermal destruction of the intraosseous basivertebral nerve (BVN) to treat vertebrogenic low back pain.
NANS Continues Coverage Advocacy on PNS
As part of its ongoing efforts to protect patient access to evidence-based therapies, NANS has submitted a formal comment letter to Cigna regarding Medical Coverage Policy 0539, which currently classifies Peripheral Nerve Stimulation (PNS) as “not medically necessary.”
WISeR Program Begins January 1, 2026
The WISeR program has released its list of the Model Participants.
What the 2026 Medicare Final Rules Mean for Neuromodulation and Pain Practices
NANS Members: Visit the NANS eLearning platform to download a workbook with full details of how Medicare changes affect neuromodulation, pain, evaluation and management and telemedicine in 2026.